Press Releases

Syapse announced today the commercial launch of Discovery, its cloud-based application for making omics data actionable in clinical research and development. Discovery combines a powerful platform for aggregating and structuring biomedical data with intuitive...

Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announces today the appointment of Christine Placet as chief executive officer, effective immediately. ...

Cytheris SA, a privately held clinical-stage biopharmaceutical company focused on treating lymphopenia driven diseases, announces today the appointment of Damian Marron as chief executive officer. Damian was previously CEO at Trophos SA. The first task...

Sanofi announced today that the marketing authorization application for Lyxumia, an investigational once-daily GLP-1 receptor agonist has been submitted for review to the Ministry of Health, Labour and Welfare in Japan. The application is...

AIDS Healthcare Foundation (AHF), the nation’s largest HIV/AIDS nonprofit medical provider, welcomed the news today that the Food and Drug Administration (FDA) is delaying a ruling on and application by Gilead Sciences for the possible approval of the...

The American Association for Homecare reported in this week's Mobility Matters publication that the U.S. Department of Health and Human Services (HHS) has uncovered serious flaws in the methodology used to calculate the error rate on payments for...

The previously announced $1.25 billion sale of the Thomson Reuters Healthcare business to an affiliate of Veritas Capital was completed today. The company’s many well-known brands, established in more than 30 years of leadership in the...